TY  - CHAP
M1  - Book, Section
TI  - Cardiovascular Disease Prevention in Women
A1  - Dolan, Brigid
A1  - Walsh, Judith
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2022
T2  - Current Medical Diagnosis & Treatment 2022
AB  - Cardiovascular  disease  is  the  leading  cause  of  death  in  women.  Women’s  heart  disease  risk  tends  to  lag  about  10  years  behind  that  of  men;  thus,  at  any  given  age,  a  woman’s  baseline  risk  will  be  lower  than  that  of  a  man’s  baseline  risk.  While  some  heart  disease  risk  factors  such  as  age  and  family  history  are  not  modifiable,  other  risk  factors  such  as  hypertension,  hyperlipidemia,  smoking,  obesity,  and  diabetes  are  potentially  modifiable.  Additionally,  sex-specific  risk  factors  may  impact  a  woman’s  risk  of  future  heart  disease,  including  adverse  pregnancy  outcomes  (ie,  preeclampsia,  gestational  diabetes,  preterm  birth,  or  small  for  gestational  age  birth),  premature  ovarian  failure  or  early  menopause,  or  comorbidities  such  as  autoimmune  disease  or  the  sequelae  of  cancer  treatments  (ie,  chest  wall  radiation,  or  trastuzumab  or  anthracycline  treatment  for  breast  cancer).  Each  of  these  may  be  considered  a  “risk-enhancer”  when  considering  future  cardiovascular  disease  risk.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/24
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1184155227
ER  -